Pearce Samantha
EVP, Chief Commercial Officer · 8 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | JAZZ | Jazz Pharmaceuticals plc | Tax withholding | 2,527 | $237.72 | $600,718.44 | filing |
| 2026-05-28 | JAZZ | Jazz Pharmaceuticals plc | Sale | 6,907 | $235.41 | $1.6M | filing |
| 2026-05-28 | JAZZ | Jazz Pharmaceuticals plc | Option exercise | 6,907 | $109.45 | $755,971.15 | filing |
| 2026-03-05 | JAZZ | Jazz Pharmaceuticals plc | Tax withholding | 2,503 | $188.69 | $472,291.07 | filing |
| 2026-02-26 | JAZZ | Jazz Pharmaceuticals plc | Award | 9,782 | $0.00 | $0.00 | filing |
| 2026-01-16 | JAZZ | Jazz Pharmaceuticals plc | Tax withholding | 1,599 | $171.16 | $273,684.84 | filing |
| 2026-01-16 | JAZZ | Jazz Pharmaceuticals plc | Award | 3,637 | $0.00 | $0.00 | filing |
| 2025-08-05 | JAZZ | Jazz Pharmaceuticals plc | Tax withholding | 577 | $116.10 | $66,989.70 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.